Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis have?
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis has 170 citations in the OpenAlex counts ScholarIQ stores.
When was Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis published?
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis has 2009 year in the ScholarIQ index.
What is the open-access status of Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis has bronze oa status in the ScholarIQ index.
What is the DOI of Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
The DOI for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is on the source record.
What is the PMID of Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
The PMID for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is on the source record.
What is the OpenAlex record for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis?
The OpenAlex for Gene expression profiling of advanced‐stage serous ovarian cancers distinguishes novel subclasses and implicates <i>ZEB2</i> in tumor progression and prognosis is on the source record.